Literature DB >> 22359311

Epigenetic biomarkers in cancer epidemiology.

Mukesh Verma1.   

Abstract

Biochemical, epigenetic, genetic, and imaging biomarkers are used to identify people at high risk for developing cancer. In cancer epidemiology, epigenetic biomarkers offer advantages over other types of biomarkers because they are expressed against a person's genetic background and environmental exposure, and because epigenetic events occur early in cancer development. This chapter describes epigenetic biomarkers that are being used to study the epidemiology of different types of cancer. Because epigenetic alterations can be reversed by chemicals and activate gene expression, epigenetic biomarkers potentially have numerous clinical applications in cancer intervention and treatment and significant implications in public health. This review discusses cancer biomarkers, the characteristics of an ideal biomarker for cancer, and technologies for biomarker detection.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22359311     DOI： 10.1007/978-1-61779-612-8_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  7 in total

1.  Core Canonical Pathways Involved in Developing Human Glioblastoma Multiforme (GBM).

Authors:  Somiranjan Ghosh; Sisir Dutta; Gabriel Thorne; Ava Boston; Alexis Barfield; Narendra Banerjee; Rayshawn Walker; Hirendra Nath Banerjee
Journal:  Int J Sci Res Sci Eng Technol       Date:  2017-02-01

Review 2.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

3.  Epigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibility.

Authors:  Francis L Martin
Journal:  ISRN Oncol       Date:  2013-02-03

4.  GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men.

Authors:  Lars Wallentin; Björn Zethelius; Lars Berglund; Kai M Eggers; Lars Lind; Bertil Lindahl; Kai C Wollert; Agneta Siegbahn
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 5.  DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Authors:  Geórgia Muccillo Dexheimer; Jayse Alves; Laura Reckziegel; Gabrielle Lazzaretti; Ana Lucia Abujamra
Journal:  Dis Markers       Date:  2017-09-06       Impact factor: 3.434

Review 6.  An Overview of DNA Methylation Indicators for the Course of Oral Precancer.

Authors:  Wenjing Wang; Wei Li; Hongyi Zhang
Journal:  Appl Bionics Biomech       Date:  2022-08-26       Impact factor: 1.664

Review 7.  DNA methylation markers for oral pre-cancer progression: A critical review.

Authors:  Krithiga Shridhar; Gagandeep Kaur Walia; Aastha Aggarwal; Smriti Gulati; A V Geetha; Dorairaj Prabhakaran; Preet K Dhillon; Preetha Rajaraman
Journal:  Oral Oncol       Date:  2015-12-12       Impact factor: 5.972
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.